Physiological aging in older adults with cancer: Implications for treatment decision making and toxicity management

Journal of Gerontological Nursing

Volumn 36, Issue 2, 2010, Pages 26-39

  Bond, Stewart M ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF NURSING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

AGED; AGING; BONE MARROW DISEASE; CHEMICALLY INDUCED; DECISION MAKING; GERIATRIC ASSESSMENT; HEART DISEASE; HUMAN; METABOLISM; MUSCULOSKELETAL DISEASE; NEOPLASMS; NEUROLOGIC DISEASE; PATIENT SELECTION; PHYSIOLOGY; PRACTICE GUIDELINE; PROCEDURES; SAFETY; STOMATITIS; UNITED STATES;

AGED; AGING; ANTINEOPLASTIC AGENTS; BONE MARROW DISEASES; DECISION MAKING; GERIATRIC ASSESSMENT; HEART DISEASES; HUMANS; MUSCULOSKELETAL DISEASES; NEOPLASMS; NERVOUS SYSTEM DISEASES; PATIENT SELECTION; PRACTICE GUIDELINES AS TOPIC; SAFETY MANAGEMENT; STOMATITIS; UNITED STATES;

EID: 77955894719     PISSN: 00989134     EISSN: None     Source Type: Journal    
DOI: 10.3928/00989134-20091103-98     Document Type: Article

References (78)

1. Aalami, O.O., Fang, T.D., Song, H.M., & Nacamuli, R.P. (2003). Physiological features of aging persons. Archives of Surgery, 138, 1068-1076.
2. Abayomi, O.K. (2002). Pathogenesis of cognitive decline following therapeutic irradiation for head and neck tumors. Acta Oncologica, 41, 346-351.
3. Adams, J.M., & White, M. (2004). Biological ageing: A fundamental, biological link between socio-economic status and health? European Journal of Public Health, 14, 331-334.
4. Altundag, K., Dede, D., Harputluoglu, H., & Gullu, I. (2007). Aromatase inhibitor-associated arthralgias: Pathogenesis, frequency and management. Joint, Bone, Spine, 74, 662-663.
5. Armstrong, T., Almadrones, L., & Gilbert, M.R. (2005). Chemotherapy-induced peripheral neuropathy. Oncology Nursing Forum, 32, 305-311.
6. Balducci, L., Hardy, C.L., & Lyman, G.H. (2000). Hemopoietic reserve in the older cancer patient: Clinical and economic considerations. Cancer Control, 7, 539-547.
7. Balducci, L., & Repetto, L. (2004). Increased risk of myelotoxicity in elderly patients with non-Hodgkin lymphoma: The case for routine prophylaxis with colony-stimulating factor beginning in the first cycle of chemotherapy. Cancer, 100, 6-11.
8. Bond, S.M. (2006). Symptom management of mucositis. In D.G. Cope & A.M. Reb (Eds.), An evidence-based approach to the treatment and care of the older adult with cancer (pp. 349-365). Pittsburgh, PA: Oncology Nursing Society.
9. Bond, S.M. (2009). Delirium at home: Strategies for home health clinicians. Home Healthcare Nurse, 27, 24-34.
10. Capo, G., & Waltzman, R. (2004). Managing hematologic toxicities. Journal of Supportive Oncology, 2, 65-79.
11. Chanan-Khan, A., Srinivasan, S., & Czuczman, M.S. (2004). Prevention and management of cardiotoxicity from antineoplastic therapy. Journal of Supportive Oncology, 2, 251-256.
12. Chen, H., Cantor, A., Meyer, J., Corcoran, M.B., Grendys, E., Cavanaugh, D., et al. (2003). Can older cancer patients tolerate chemotherapy? A prospective pilot study. Cancer, 97, 1107-1114.
13. Crawford, J., Dale, D.C., & Lyman, G.H. (2004). Chemotherapy-induced neutropenia: Risks, consequences, and new directions for its management. Cancer, 100, 228-237.
14. Crew, K.D., Greenlee, H., Capodice, J., Raptis, G., Brafman, L., Fuentes, D., et al. (2007). Prevalence of joint symptoms in postmenopausal women taking aromatase inhibitors for early-stage breast cancer. Journal of Clinical Oncology, 25, 3877-3883.
15. Crighton, M.H., & Puppione, A.A. (2006). Geriatric neutrophils: Implications for older adults. Seminars in Oncology Nursing, 22, 3-9.
16. Crivellari, D., Magri, M.D., Buonadonna, A., Lombardi, D., Paolello, C., De Cicco, M., et al. (2000). Continuous infusion fluorouracil in the management of advanced breast cancer: A phase II study. Tumori, 86, 42-45.
17. Dees, E.C., O'Reilly, S., Goodman, S.N., Sartorius, S., Levine, M.A., Jones, R.J., et al. (2000). A prospective pharmacologic evaluation of age-related toxicity of adjuvant chemotherapy in women with breast cancer. Cancer Investigation, 18, 521-529.
18. Elmadfa, I., & Meyer, A.L. (2008). Body composition, changing physiological functions and nutrient requirements of the elderly. Annals of Nutrition and Metabolism, 52(Suppl. 1), 2-5.
19. Elting, L.S., Cooksley, C., Chambers, M., Cantor, S.B., Manzullo, E., & Rubenstein, E.B. (2003). The burdens of cancer therapy: Clinical and economic outcomes of chemotherapy-induced mucositis. Cancer, 98, 1531-1539.
20. Extermann, M. (2003). Studies of comprehensive geriatric assessment in patients with cancer. Cancer Control, 10, 463-468.
21. Extermann, M. (2004). Management issues for elderly patients with breast cancer. Current Treatment Options in Oncology, 5, 161-169.
22. Extermann, M. (2005). Older patients, cognitive impairment, and cancer: An increasingly frequent triad. Journal of the National Comprehensive Cancer Network, 3, 593-596.
23. Extermann, M., Aapro, M., Bernabei, R., Cohen, H.J., Droz, J.P., Lichtman, S., et al. (2005). Use of comprehensive geriatric assessment in older cancer patients: Recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG). Critical Reviews in Oncology/Hematology, 55, 241-252.
24. Extermann, M., Overcash, J., Lyman, G.H., Parr, J., & Balducci, L. (1998). Comorbidity and functional status are independent in older cancer patients. Journal of Clinical Oncology, 16, 1582-1587.
25. Firat, S., Bousamra, M., Gore, E., & Byhardt, R.W. (2002). Comorbidity and KPS are independent prognostic factors in stage I non-small-cell lung cancer. International Journal of Radiation Oncology, Biology, and Physics, 52, 1047-1057.
26. Frasci, G., Lorusso, V., Panza, N., Comella, P., Nicolella, G., Bianco, A., et al. (2000). Gemcitabine plus vinorelbine versus vinorelbine alone in elderly patients with advanced non-small-cell lung cancer. Journal of Clinical Oncology, 18, 2529-2536.
27. Freyer, G., Geay, J.F., Touzet, S., Provencal, J., Weber, B., Jacquin, J.P., et al. (2005). Comprehensive geriatric assessment predicts tolerance to chemotherapy and survival in elderly patients with advanced ovarian carcinoma: A GINECO study. Annals of Oncology, 16, 1795-1800.
28. Harris, D.J., Eilers, J., Harriman, A., Cashavelly, B.J., & Maxwell, C. (2008). Putting evidence into practice: Evidence-based interventions for the management of oral mucositis. Clinical Journal of Oncology Nursing, 12, 141-152.
29. Hazzard, W.R. (2000). The clinical physiology of aging. International Urology and Nephrology, 32, 137-146.
30. Hillner, B.E., Ingle, J.N., Chlebowski, R.T., Gralow, J., Yee, G.C., Janjan, N.A., et al. (2003). American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer. Journal of Clinical Oncology, 21, 4042-4057.
31. Hurria, A., Gupta, S., Zauderer, M., Zuckerman, E.L., Cohen, H.J., Muss, H., et al. (2005). Developing a cancer-specific geriatric assessment: A feasibility study. Cancer, 104, 1998-2005.
32. Hurria, A., Lichtman, S.M., Gardes, J., Li, D., Limaye, S., Patil, S., et al. (2007). Identifying vulnerable older adults with cancer: Integrating geriatric assessment into oncology practice. Journal of the American Geriatrics Society, 55, 1604-1608.
33. Ingram, S.S., Seo, P.H., Martell, R.E., Clipp, E.C., Doyle, M.E., Montana, G.S., et al. (2002). Comprehensive assessment of the elderly cancer patient: The feasibility of self-report methodology. Journal of Clinical Oncology, 20, 770-775.
34. Klepin, H., Mohile, S., & Hurria, A. (2009). Geriatric assessment in older patients with breast cancer. Journal of the National Comprehensive Cancer Network, 7, 226-236.
35. Kurtin, S.E. (2009). Hypertension management in the era of targeted therapies for cancer. Oncology Nurse Edition, 23(4), 41-45.
36. Lichtman, S.M. (2003). Guidelines for the treatment of elderly cancer patients. Cancer Control, 10, 445-453.
37. Lichtman, S.M., & Boparai, M.K. (2008). Anticancer drug therapy in the older cancer patient: Pharmacology and polypharmacy. Current Treatment Options in Oncology, 9, 191-203.
38. Lichtman, S.M., Wildiers, H., Chatelut, E., Steer, C., Budman, D., Morrison, V.A., et al. (2007). International Society of Geriatric Oncology Chemotherapy Taskforce: Evaluation of chemotherapy in older patients-An analysis of the medical literature. Journal of Clinical Oncology, 25, 1832-1843.
39. Limburg, C.E. (2007). Screening, prevention, detection, and treatment of cancer therapy-induced bone loss in patients with breast cancer. Oncology Nursing Forum, 34, 55-62.
40. Luckey, A.E., & Parsa, C.J. (2003). Fluid and electrolytes in the aged. Archives of Surgery, 138, 1055-1060.
41. Maione, P., Perrone, F., Gallo, C., Manzione, L., Piantedosi, F.V., Barbera, S., et al. (2005). Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: A prognostic analysis of the multicenter Italian Lung Cancer in the Elderly study. Journal of Clinical Oncology, 23, 6865-6872.
42. Marrs, J., & Newton, S. (2003). Updating your peripheral neuropathy "know-how." Clinical Journal of Oncology Nursing, 7, 299-303.
43. Maxwell, C., & Viale, P.H. (2005). Cancer treatment-induced bone loss in patients with breast and prostate cancer. Oncology Nursing Forum, 32, 589-603.
44. Meinardi, M.T., Gietema, J.A., van Veldhuisen, D.J., van der Graaf, W.T.A., de Vries, E.G.E., & Sleijfer, D.T. (2000). Long-term chemotherapy-related cardiovascular morbidity. Cancer Treatment Reviews, 26, 429-447.
45. Murphy, B.A. (2007). Clinical and economic consequences of mucositis induced by chemotherapy and/or radiation. Journal of Supportive Oncology, 5(9 Suppl. 4), 13-21.
46. Myers, J.S. (2008). Factors associated with changing cognitive function in older adults: Implications for nursing rehabilitation. Rehabilitation Nursing, 33, 117-123.
47. National Comprehensive Cancer Network. (2009a). NCCN clinical practice guidelines in oncology: Cancer- and chemotherapy-induced anemia (Version V.3.2009). Retrieved from http://www.NCCN.org
48. National Comprehensive Cancer Network. (2009b). NCCN clinical practice guidelines in oncology: Myeloid growth factors (Version V.1.2009). Retrieved from http://www.NCCN.org
49. National Comprehensive Cancer Network. (2009c). NCCN clinical practice guidelines in oncology: Senior adult oncology (Version V.1.2009). Retrieved from http://www.NCCN.org
50. Overcash, J.A., Beckstead, J., Moody, L., Extermann, M., & Cobb, S. (2006). The abbreviated Comprehensive Geriatric Assessment (aCGA) for use in the older cancer patients as a prescreen: Scoring and interpretation. Critical Reviews in Oncology/Hematology, 59, 205-210.
51. Penninx, B.W., Cohen, H.J., & Woodman, R.C. (2007). Anemia and cancer in older persons. Journal of Supportive Oncology, 5, 107-113.
52. Pfeilschifter, J., & Diel, I.J. (2000). Osteoporosis due to cancer treatment: Pathogenesis and management. Journal of Clinical Oncology, 18, 1570-1593.
53. Piccirillo, J.F., Tierney, R.M., Costas, I., Grove, L., & Spitznagel, E.L., Jr. (2004). Prognostic importance of comorbidity in a hospital-based cancer registry. Journal of the American Medical Association, 291, 2441-2447.
54. Pinder, M.C., Duan, Z., Goodwin, J.S., Hortobagyi, G.N., & Giordano, S.H. (2007). Congestive heart failure in older women treatment with adjuvant anthracycline chemotherapy for breast cancer. Journal of Clinical Oncology, 25, 3808-3815.
55. Plotkin, S.R., & Wen, P.Y. (2003). Neurologic complications of cancer therapy. Neurologic Clinics, 21, 279-318.
56. Quasthoff, S., & Hartung, H.P. (2002). Chemotherapy-induced peripheral neuropathy. Journal of Neurology, 249, 9-17.
57. Reuben, D.B., Herr, K.A., Pacala, J.T., Pollock, B.G., Potter, J.F., & Semla, T.P. (2009). Geriatrics at your fingertips: 2009 (11th ed.). New York: American Geriatrics Society.
58. Saltzstein, S.L., & Behling, C.A. (2002). 5- and 10-year survival in cancer patients aged 90 and older: A study of 37,318 patients from SEER. Journal of Surgical Oncology, 81, 113-116.
59. Sawhney, R., Sehl, M., & Naeim, A. (2005). Physiologic aspects of aging: Impact on cancer management and decision making, part I. Cancer Journal, 11, 449-460.
60. Schrijvers, D., Highley, M., De Bruyn, E., Van Oosterom, A.T., & Vermorken, J.B. (1999). Role of red blood cells in pharmacokinetics of chemotherapeutic agents. Anticancer Drugs, 10, 147-153.
61. Sehl, M., Sawhney, R., & Naeim, A. (2005). Physiologic aspects of aging: Impact on cancer management and decision making, part II. Cancer Journal, 11, 461-473.
62. Skirvin, J.A., & Lichtman, S.M. (2002). Pharmacokinetic considerations of oral chemotherapy in elderly patients with cancer. Drugs & Aging, 19, 25-42.
63. Sonis, S.T. (2004). Oral mucositis in cancer therapy. Journal of Supportive Oncology, 2(6 Suppl. 3), 3-8.
64. Smith, B.D., Smith, G.L., Hurria, A., Hortobagyi, G.N., & Buchholz, T.A. (2009). Future of cancer incidence in the United States: Burdens upon an aging, changing nation. Journal of Clinical Oncology. Advance online publication. doi:10.1200/JCO.2008.20.8983
65. Smith, T.J., Khatcheressian, J., Lyman, G.H., Ozer, H., Armitage, J.O., Balducci, L., et al. (2006). 2006 update of recommendations for the use of white blood cell growth factors: An evidence-based clinical practice guideline. Journal of Clinical Oncology, 24, 3187-3205.
66. Stommel, M., Given, B.A., & Given, C.W. (2002). Depression and functional status as predictors of death among cancer patients. Cancer, 94, 2719-2727.
67. Sullivan, E.V., & Pfefferbaum, A. (2007). Neuroradiological characterization of normal adult ageing. British Journal of Radiology, 80(Special No. 2), S99-S108.
68. Suter, T.M., Procter, M., van Veldhuisen, D.J., Muscholl, M., Bergh, J., Carlomagno, C., et al. (2007). Trastuzumab-associated cardiac adverse effects in the Herceptin Adjuvant Trial. Journal of Clinical Oncology, 25, 3859-3865.
69. Swain, S.M., Whaley, F.S., & Ewer, M.S. (2003). Congestive heart failure in patients treated with doxorubicin: A retrospective analysis of three trials. Cancer, 97, 2869-2879.
70. Tan-Chiu, E., Yothers, G., Romond, E., Geyer, C.E., Jr., Ewer, M., Keefe, D., et al. (2005). Assessment of cardiac dysfunction in a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel, with or without trastuzumab as adjuvant therapy in node-positive, human epidermal growth factor receptor 2-overexpressing breast cancer: NSABP B-31. Journal of Clinical Oncology, 23, 7811-7189.
71. van Londen, G.J., Taxel, P., & Van Poznak, C. (2008). Cancer therapy and osteoporosis: Approach to evaluation and management. Seminars in Oncology, 35, 643-651.
72. Viale, P.H., & Yamamoto, D.S. (2008). Cardiovascular toxicity associated with cancer treatment. Clinical Journal of Oncology Nursing, 12, 627-638.
73. Visovsky, C., Collins, M., Abbott, L., Ashenbrenner, J., & Hart, C. (2007). Putting evidence into practice: Evidence-based interventions for chemotherapy-induced peripheral neuropathy. Clinical Journal of Oncology Nursing, 11, 901-913.
74. Wickham, R. (2007). Chemotherapy-induced peripheral neuropathy: A review and implications for oncology nursing practice. Clinical Journal of Oncology Nursing, 11, 361-376.
75. Winters, L., Habin, K., & Gallagher, J. (2007). Aromatase inhibitors and musculoskeletal pain in patients with breast cancer. Clinical Journal of Oncology Nursing, 11, 433-439.
76. Yancik, R., & Ries, L.A. (2000). Aging and cancer in America. Demographics and epidemiologic perspectives. Hematology/Oncology Clinics of North America, 14, 17-23.
77. Yancik, R., Wesley, M.N., Ries, L.A., Havlik, R.J., Long, S., Edwards, B.K., et al. (1998). Comorbidity and age as predictors of risk for early mortality of male and female colon carcinoma patients: A population-based study. Cancer, 82, 2123-2134.
78. Zitella, L.J., Friese, C.R., Hauser, J., Gobel, B.H., Woolery, M., O'Leary, C., et al. (2006). Putting evidence into practice: Prevention of infection. Clinical Journal of Oncology Nursing, 10, 739-750.